A Psychological-behavioral Intervention to Increase Activity in Type 2 Diabetes
BEHOLD-16
1 other identifier
interventional
70
1 country
1
Brief Summary
The focus of this study is to examine the feasibility, acceptability, and impact of a customized, combined positive psychology and motivational interviewing (PP-MI) health behavior intervention in a group of patients with type 2 diabetes (T2D).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable type-2-diabetes-mellitus
Started Jul 2017
Typical duration for not_applicable type-2-diabetes-mellitus
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 22, 2017
CompletedFirst Posted
Study publicly available on registry
May 23, 2017
CompletedStudy Start
First participant enrolled
July 25, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 10, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
October 10, 2019
CompletedResults Posted
Study results publicly available
February 21, 2021
CompletedFebruary 21, 2021
February 1, 2021
2.2 years
May 22, 2017
May 6, 2020
February 2, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Number of PP-MI Sessions Completed by Participants
Measured by number of PP-MI sessions completed by participants in the PP-MI group.
16 weeks
Secondary Outcomes (15)
Ease of PP Component
Weeks 1-16
Ease of MI Component
Weeks 1-16
Utility of PP Component
Weeks 1-16
Utility of MI Component
Weeks 1-16
Change in Moderate-Vigorous Physical Activity
Change from Baseline to 16 weeks, and Baseline to 24 weeks
- +10 more secondary outcomes
Other Outcomes (9)
Change in Medication Adherence
Change in score from Baseline to 16 weeks, and Baseline to 24 weeks
Change in Self-Reported Physical Activity
Change in score from Baseline to 16 weeks, and Baseline to 24 weeks
Change in Physical Function
Change in score from Baseline to 16 weeks, and Baseline to 24 weeks
- +6 more other outcomes
Study Arms (2)
Positive Psychology + Motivational Interviewing
EXPERIMENTALParticipants will complete weekly positive psychology exercises and will systematically set goals related to physical activity. Study trainers will review the positive psychology exercises on the phone each week and will use motivational interviewing techniques to facilitate goal setting.
Diabetes Education
ACTIVE COMPARATORParticipants will speak on the telephone each week with a study trainer. During these calls, the trainer will provide education about a health behavior related to diabetes health (physical activity, medication adherence, diet).
Interventions
Participants randomized to PP-MI will receive a treatment manual. For each session, a PP exercise will be described in the manual, with instructions and space to write about the exercise and its effects. Next, an MI section will outline specific MI-based topics (e.g., pros/cons, managing slips) and facilitate physical activity goal-setting. Following randomization, participants will engage in weekly, 30-minute phone calls over the next 16 weeks. Participants will independently complete PP exercises and MI-based goals between phone sessions and review them during phone sessions. PP and MI components will be delivered stepwise within sessions (rather than intertwined).
Each week, participants will learn about a different health behavior topic related to diabetes health. As an attentional control, this condition has a parallel structure to the experimental arm with a treatment manual, weekly assignments, and weekly calls to review assignments.
Eligibility Criteria
You may qualify if:
- T2D. Eligible patients will meet American Diabetes Association (ADA) criteria for T2D (e.g., HbA1c \[A1C\] ≥6.5%, fasting glucose ≥126 mg/d), with diagnosis confirmed by their diabetes clinician and/or medical record review.
- Low physical activity. Low physical activity will be defined as ≤150 minutes/week of MVPA (corresponding to ADA recommendations for moderate or greater intensity aerobic physical activity). Physical activity will be measured using a brief questionnaire adapted from the International Physical Activity Questionnaire (IPAQ).
You may not qualify if:
- Cognitive impairment precluding consent or meaningful participation.
- Lack of phone availability.
- Inability to read/write in English.
- Additional medical conditions (e.g., severe arthritis) that preclude physical activity.
- Enrollment in mind-body programs, lifestyle intervention programs (e.g., cardiac rehabilitation), or other clinical trials.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Jeff Huffman
- Organization
- Massachusetts General Hospital
Study Officials
- PRINCIPAL INVESTIGATOR
Jeff C Huffman, MD
Massachusetts General Hospital
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Chief of Psychiatry for Clinical Services
Study Record Dates
First Submitted
May 22, 2017
First Posted
May 23, 2017
Study Start
July 25, 2017
Primary Completion
October 10, 2019
Study Completion
October 10, 2019
Last Updated
February 21, 2021
Results First Posted
February 21, 2021
Record last verified: 2021-02
Data Sharing
- IPD Sharing
- Will not share